Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Advancements In The Cystic Fibrosis Therapeutics Treatment
3.2.2. Increasing Incidence Of Cystic Fibrosis (Cf)
3.2.3. Rise In The R&D Of Novel Cystic Fibrosis Therapeutics
3.3. Key Restraints
3.3.1. Stringent Regulation
3.3.2. Low Awareness Among Developing Economies

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Pestel Analysis
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Route Of Administration
5.1. Inhale
5.2. Oral

6. Market By Drug Class
6.1. Cftr Modulators
6.2. Bronchodilators
6.3. Mucolytic
6.4. Pancreatic Enzyme Supplements

7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. Japan
7.1.3. India
7.1.4. Australia & New Zealand
7.1.5. South Korea
7.1.6. Thailand
7.1.7. Indonesia
7.1.8. Vietnam
7.1.9. Rest Of Asia Pacific

8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Agilent Technologies Inc
8.4. Allergan Plc
8.5. F. Hoffmann-La Roche
8.6. Gilead Sciences Inc
8.7. Glaxosmithkline Plc
8.8. Johnson & Johnson
8.9. Mylan N.V
8.10. Novartis Ag
8.11. Perkinelmer
8.12. Pfizer Inc
8.13. Pharmaxis Ltd
8.14. Teva Pharmaceutical Industries Ltd
8.15. Vertex Pharmaceuticals Incorporated



List of Figures


List of Figures

Figure 1: Porter’S Five Forces Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Asia Pacific Cystic Fibrosis Therapeutics, By Route Of Administration, In 2019
Figure 6: Asia Pacific Cystic Fibrosis Therapeutics Market, By Inhale, 2020-2028 (In $ Million)
Figure 7: Asia Pacific Cystic Fibrosis Therapeutics Market, By Oral, 2020-2028 (In $ Million)
Figure 8: Asia Pacific Cystic Fibrosis Therapeutics, By Drug Class, In 2019
Figure 9: Asia Pacific Cystic Fibrosis Therapeutics Market, By Cftr Modulators, 2020-2028 (In $ Million)
Figure 10: Asia Pacific Cystic Fibrosis Therapeutics Market, By Bronchodilators, 2020-2028 (In $ Million)
Figure 11: Asia Pacific Cystic Fibrosis Therapeutics Market, By Mucolytic, 2020-2028 (In $ Million)
Figure 12: Asia Pacific Cystic Fibrosis Therapeutics Market, By Pancreatic Enzyme Supplements, 2020-2028 (In $ Million)
Figure 13: Asia Pacific Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 14: China Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 15: Japan Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 16: India Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 17: Australia & New Zealand Cystic Fibrosis Therapeutics, 2020-2028 (In $ Million)
Figure 18: South Korea Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 19: Thailand Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 20: Indonesia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 21: Vietnam Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 22: Rest Of Asia Pacific Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)


List of Tables


List of Tables

TABLE 1: MARKET SNAPSHOT - VETERINARY VACCINE
TABLE 2: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC INHALE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC INHALE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC ORAL MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: ASIA PACIFIC ORAL MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: ASIA PACIFIC CFTR MODULATORS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: LIST OF CFTR MODULATORS GENERIC AND BRAND NAME
TABLE 12: ASIA PACIFIC CFTR MODULATORS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 13: ASIA PACIFIC BRONCHODILATORS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: LIST OF BRONCHODILATORS GENERIC AND BRAND NAME
TABLE 15: ASIA PACIFIC BRONCHODILATORS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: ASIA PACIFIC MUCOLYTIC MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: LIST OF MUCOLYTICS GENERIC AND BRAND NAME
TABLE 18: ASIA PACIFIC MUCOLYTIC MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 19: ASIA PACIFIC PANCREATIC ENZYME SUPPLEMENTS MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: ASIA PACIFIC PANCREATIC ENZYME SUPPLEMENTS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 21: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)